Vanderbilt Ingram Cancer Center

In a town full of amazing singers, Nashville songstress Dawn Sears’ voice was something special. Read More

Marco Davila, M.D., Ph.D., assistant professor of Medicine and of Cancer Biology, has received a grant from the Damon Runyon Cancer Research Foundation that will provide $450,000 over three years to help fund his research on therapies for several types of blood disorders, including various forms of leukemia and non-Hodgkin (also known as non-Hodgkin’s) lymphoma. Read More

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), recently joined other cancer research leaders in a meeting with members of Congress to discuss precision medicine in cancer and the need for continued federal support for cancer research. Read More

The 2015 Annual Meeting of the American Society of Clinical Oncology, held May 29 - June 2 in Chicago, put multiple Vanderbilt-Ingram Cancer Center investigators in the spotlight. Read More

Vanderbilt University Medical Center has again been recognized for a strong and enduring commitment to helping employees and their families live healthy lives. Read More

Pierre Massion, M.D., director of the Thoracic Program and an Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has been recognized for his pioneering work in lung cancer by the LUNGevity Foundation. Read More

A Nashville-based dietitian who lost her mother to cancer is using the power of social media to raise funds for chemo care bags for cancer patients. Read More

Lauren Hackett, MPA, executive director of Administration at Vanderbilt-Ingram Cancer Center (VICC) and chief business officer for Oncology, Imaging and Quantitative Sciences Administration, has been chosen as one of the 2015 Women to Watch by Nashville Medical News. Read More

Efforts to enable the immune system to “see” the cancer and attack the aberrant cells were the prime focus during Vanderbilt-Ingram Cancer Center’s Annual Retreat, held April 30 at the Vanderbilt University Student Life Center. Read More

Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research. Read More

Lisa Kachnic, M.D., professor and chair of Radiation Oncology and associate director of Multidisciplinary Cancer Research at Boston University School of Medicine (BUSM), and chief of Radiation Oncology at Boston Medical Center (BMC), has been named the new professor and chair of the Vanderbilt Department of Radiation Oncology. She will join the faculty on Sept. 21. Read More

Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer. Read More

The Vanderbilt-Ingram Cancer Center (VICC) at Franklin has added new technology to enhance treatment for patients needing radiation therapy or stereotactic body radiation. Read More

Vanderbilt’s Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center are providing free head and neck cancer screenings Friday, April 17. The screenings are open to the public and no appointments are needed. Read More

Of every 100 people in the United States, at least three men or women will be diagnosed with head and neck cancer in their lifetimes. These cancers can occur in the nasal cavity, sinuses, throat, lips, mouth, thyroid, salivary glands or the voice box (larynx). Read More

Vanderbilt-Ingram Cancer Center investigators have identified the mechanisms used by a gene and its binding protein to drive tumor growth in several forms of cancer, including non-small cell lung cancer. Read More

Douglas Johnson, M.D. Douglas Johnson, M.D., assistant professor of Medicine, has been named a recipient of the National Comprehensive Cancer Network (NCCN) Foundation Young Investigator Awards. The two-year grant will provide $150,000 in funding for his research on survivorship among cancer patients who receive drugs… Read More

Vanderbilt-Ingram Cancer Center, along with Nashville Public Television (NPT), the American Cancer Society and Gilda’s Club Nashville, will sponsor a special community event to preview an upcoming PBS television documentary on cancer. Read More

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators. Read More

Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies. Read More